BACKGROUND: Dorsal root ganglion (DRG) stimulation therapy has been shown to provide effective relief in controlling chronic regional pain syndrome (CRPS)-related pain; however, there is little information on its efficacy and safety in pediatric patients. CASE REPORT: Following Institutional Review Board approval, a review of pediatric patients who underwent DRG therapy at a single university pain center was conducted. Five patients under 18 years old with CRPS or intercostal neuralgia who failed prior therapies received DRG stimulation therapy. Three of 5 patients (60%) reported 50% or more relief with DRG therapy. Secondary outcomes including resolution of allodynia, sudomotor and vasomotor dysfunction, and tropic changes as well as school/work attendance and reduced physical restrictions at the longest follow-up were improved in responders. CONCLUSION: In our limited series we found substantially improved analgesia, reduction in symptoms of CRPS, and improved functional outcomes in pediatric patients treated with DRG neuromodulation for unresponsive chronic pain. KEY WORDS: Chronic regional pain syndrome, intercostal neuralgia, neuromodulation, pediatric
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.